___

• Shaw PJ. Stiff-man syndrome and its variants. Lancet. 1999 Jan
• ;353(9147):86-7.
• Grimaldi LM, Martino G, Braghi S, Quattrini A, Furlan R, Bosi E, Comi G.
• Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol. 1993
• Jul;34(1):57-64.
• De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, Meinck HM,
• Austoni M, Fassetta G, Bottazzo G, Bates D, Cartlidge N, Solimena M,
• Kilimann MW, et al. The synaptic vesicle-associated protein amphiphysin
• is the 128-kD autoantigen ofStiff-Man syndrome with breast cancer. J Exp
• Med. 1993 Dec 1;178(6):2219-23.
• Stayer C, Meinck HM. Stiff-man syndrome: an overview. Neurologia. 1998
• Feb;13(2):83-8.
• Kimura, J.Electrodiagnosis is Diseases of Nerve and Muscle: Principles and
• Practice, 2nd edition, FA Davis, Philadelphia, 1989.
• Krishna VR, Knievel K, Ladha S, Sivakumar K. Lower extremity predominant
• stiff-person syndrome and limbic encephalitis with amphiphysin antibodies
• in breast cancer. J Clin Neuromuscul Dis. 2012 Dec;14(2):72-4.
• Nguyen-Huu BK1, Urban PP, Schreckenberger M, Dieterich M, Werhahn KJ.
• Antiamphiphysin-positive stiff-person syndrome associated with small cell
• lung cancer. Mov Disord. 2006 Aug;21(8):1285-7.
• Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to
• GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N
• Engl J Med. 1990 May 31;322(22):1555-60.